Purchase Order 75N91025P00011

Award Date 11/1/24
Potential Completion Date 12/31/25
Potential Value $250K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Evanston, IL 60208, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the National Cancer Institute to The Washington University for $249,997 to provide medical record abstraction services in support of a study comparing pediatric proton and photon radiation therapy. The 14-month contract does not have a set-aside designation. The services will involve retrieving de-identified clinical and treatment data from medical records of pediatric cancer patients treated with proton or photon radiotherapy. This contract...
This is a firm-fixed-price contract awarded by the National Cancer Institute (NCI) to Princeton Procure Management LLC (Procure Proton Center) for $150,150 to provide medical record abstraction services for a study comparing pediatric proton and photon radiotherapy. The 14-month contract, which starts on or about November 1, 2024, is part of NCI's Pediatric Proton and Photon Therapy Comparison Cohort program. The contractor will retrieve de-identified clinical and treatment data from medical...
This firm fixed price purchase order awarded by the National Institutes of Health's National Cancer Institute to Mayo Clinic seeks to obtain clinical data on pediatric cancer patients treated with proton therapy or photon therapy. The goal is to retrieve existing diagnosis and treatment data from medical records of eligible patients treated since January 2007 at contractor institutions and enter de-identified data into a secure database to serve as a comparison cohort for a US Pediatric Proton...
The National Cancer Institute (NCI) has awarded a $248,767 firm fixed-price purchase order contract to Proton Doctors Professional Corporation for the US Pediatric Proton and Photon Therapy Cohort, a retrospective cohort study comparing risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. This contract is not set-aside. The goal is to obtain de-identified clinical and treatment data from existing medical records of eligible pediatric patients treated with...
This is a $250,000.00 firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Baylor College of Medicine for the US Pediatric Proton and Photon Therapy Cohort study. The contract, which has no set-aside designation, requires Baylor to retrieve de-identified clinical and treatment data from existing medical records of eligible pediatric cancer patients treated with proton or photon therapy at their institution. This data will be used to evaluate the risks and benefits of...
This is a firm-fixed-price purchase order awarded by the National Cancer Institute (NCI) to Mayo Clinic Arizona, doing business as Mayo Clinic Hospital, for $252,134 to provide medical record abstraction services for a pediatric proton and photon therapy comparison cohort study. The 14-month contract has an anticipated start date of November 1, 2024. The services will be performed remotely by Mayo Clinic Arizona, which has an extensive history as a prime contractor delivering diagnostic and...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Cancer Institute (NCI) to the University of Florida Division of Sponsored Research. The contract has a potential value of $159,826.00 and a period of performance ending on March 15, 2023. The contract is part of the US Pediatric Proton/Photon Therapy Cohort Study, which aims to obtain data on pediatric cancer patients treated with proton or photon therapy. The contract was...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (DHHS) National Institutes of Health (NIH) National Cancer Institute to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a non-profit hospital and research institution. The $249,997.00 contract will obtain data on a cohort of pediatric cancer patients treated with proton therapy and a comparison group treated with photon therapy, to serve as part of a...
The National Cancer Institute (NCI) awarded a $249,814 firm fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, to establish the US Pediatric Proton and Photon Therapy Cohort. This retrospective cohort study will compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data...
The National Cancer Institute (NCI) awarded a $293,970 firm fixed-price purchase order to the University Health Network (UHN), doing business as the Toronto General And Western Hospital Foundation, to retrieve existing clinical and treatment data for at least 500 pediatric cancer patients treated with photon therapy since 2007. This data will be used to evaluate photon therapy as a cancer treatment for pediatric patients as part of the U.S. Pediatric Photon Therapy Comparison Cohort Study. The...

This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Northwestern University for $250,000 to provide medical record abstraction services for a study comparing pediatric cancer patients treated with proton versus photon radiation therapy. The services will be performed remotely, and the period of performance is a 14-month base period starting around November 1, 2024. This requirement was competed under simplified acquisition procedures without a set-aside designation. The procurement supports NCI's research efforts to evaluate the comparative risks and benefits of proton versus photon radiotherapy for pediatric cancer patients.

Generated 10/30/24, 10:03 AM